KBLB — Kraig Biocraft Laboratories, Inc.
—
OTC ·
Materials ·
Chemicals ·
CIK 1413119 ·
Last close
$0.10
Market Cap
$111.30M
52W High
$0.15
52W Low
$0.09
ADV30
815,533
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -825,500 | -942,720 | 3,721,832 | 2,890,990 | 10,783,506 |
| Dec 2025 | 0 | — | -722,668 | -787,621 | 2,565,540 | 1,790,236 | 10,564,498 |
| Sep 2025 | 0 | — | -1,433,888 | -1,509,566 | 2,356,596 | 1,565,692 | 10,312,673 |
| Jun 2025 | 0 | — | -637,745 | -726,133 | 1,591,332 | 785,462 | 10,064,196 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,884,189
Investing CF
$423,926
Financing CF
$3,954,252
CapEx
$-15,728
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-57,651,792
Inventory
$74,307
Receivables
—
ST Investments
—
EBIT TTM
$-3,387,246
Pretax Income TTM
$-3,966,040
Interest Exp TTM
$578,794
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -3,374,793 | -3,623,353 | 2,565,540 | 10,564,498 | — | -1,788,970 |
| Dec 2024 | 0 | -3,074,561 | -3,398,939 | 1,505,333 | 9,654,954 | — | -1,839,086 |
| Dec 2023 | 0 | -2,614,794 | -3,029,780 | 3,232,822 | 8,939,978 | — | -1,244,483 |
| Dec 2022 | 0 | -2,121,343 | -3,842,014 | 4,570,920 | 8,092,780 | — | -1,887,187 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMTX | AEMETIS, INC | $106.25M | $1.51 | — |
| FTLF | FITLIFE BRANDS, INC. | $93.07M | $9.91 | — |
| ACNT | ASCENT INDUSTRIES CO. | $139.82M | $15.47 | — |
| ZTEK | Zentek Ltd. | $86.10M | $0.68 | — |
| SAFX | XCF Global, Inc. | $145.31M | $0.36 | — |
News headlines (Yahoo Finance, 1h cache)
Kraig Biocraft CEO Highlights Spider Silk Commercialization Strategy in Just Style Interview (USOTC:KBLB)
2026-07-21 14:30 · Yahoo
Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication
2026-07-21 11:05 · Yahoo
Kraig Biocraft Laboratories Authority Magazine Feature Highlights Commercial-Scale Spider Silk Strategy
2026-07-10 14:50 · Yahoo
Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials
2026-07-10 11:05 · Yahoo
Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview
2026-06-15 11:05 · Yahoo
Kraig Biocraft Laboratories Sets Recombinant Spider Silk Production Record with Nearly 2.5 Metric Ton Harvest (KBLB)
2026-06-09 14:49 · Yahoo
Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle
2026-06-09 11:05 · Yahoo
Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations
2026-05-26 11:35 · Yahoo
Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform
2026-05-20 11:35 · Yahoo
Immortalized Silk Gland Cell Line Breakthrough Expands Kraig Biocraft’s Biotech Ambitions (KBLB)
2026-05-18 15:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.